soybean oil 300 MG/ML Injectable Suspension
- RxCUI
- 200318
- RxNorm name
- soybean oil 300 MG/ML Injectable Suspension
- Display name
- soybean oil 300 MG/ML Injectable Suspension
- Full name
- soybean oil 300 MG/ML Injectable Suspension
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | 98460eae-5195-48d2-ab73-00d276879ef6 | 2025-10-09 | Warnings, Adverse reactions | 200318 |
| Intralipid | I. V. FAT EMULSION | Baxter Healthcare Corporation | dd269651-30e8-43f0-880f-484346eaafeb | 2022-07-21 | Boxed warning, Adverse reactions | 200318 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 98460eae-5195-48d2-ab73-00d276879ef6 | soybean oil 30 % Injectable Suspension [PSN] · soybean oil 300 MG/ML Injectable Suspension [SCD] · soybean oil 30 % Injectable Suspension [SY] | 3 | 4 | These highlights do not include all the information needed to use INTRALIPID ® safely and effectively. See full prescribing information for INTRALIPID. INTRALIPID 30% (lipid injectable emulsion), for intravenous use Initial U.S. Approval: 1993 | 20251009 |
| dd269651-30e8-43f0-880f-484346eaafeb | soybean oil 30 % Injectable Suspension [PSN] · soybean oil 300 MG/ML Injectable Suspension [SCD] · soybean oil 30 % Injectable Suspension [SY] | 3 | 4 | Intralipid ® 30% (A 30% I.V. Fat Emulsion) | 20220721 |